国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mycoplasma hyopneumoniae Histidine--tRNA ligase (hisS) CSB-YP669989MAAU
CSB-EP669989MAAU
CSB-BP669989MAAU
CSB-MP669989MAAU
CSB-EP669989MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 30S ribosomal protein S10 (rpsJ) CSB-YP669990MAAU
CSB-EP669990MAAU
CSB-BP669990MAAU
CSB-MP669990MAAU
CSB-EP669990MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 50S ribosomal protein L14 (rplN) CSB-YP669991MAAU
CSB-EP669991MAAU
CSB-BP669991MAAU
CSB-MP669991MAAU
CSB-EP669991MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Adenylate kinase (adk) CSB-YP669992MAAU
CSB-EP669992MAAU
CSB-BP669992MAAU
CSB-MP669992MAAU
CSB-EP669992MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP669993MAAU
CSB-EP669993MAAU
CSB-BP669993MAAU
CSB-MP669993MAAU
CSB-EP669993MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 50S ribosomal protein L20 (rplT) CSB-YP669994MAAU
CSB-EP669994MAAU
CSB-BP669994MAAU
CSB-MP669994MAAU
CSB-EP669994MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Elongation factor G (fusA), partial CSB-YP669995MAAU
CSB-EP669995MAAU
CSB-BP669995MAAU
CSB-MP669995MAAU
CSB-EP669995MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 30S ribosomal protein S2 (rpsB) CSB-YP669996MAAU
CSB-EP669996MAAU
CSB-BP669996MAAU
CSB-MP669996MAAU
CSB-EP669996MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Protein RecA (recA) CSB-YP669997MAAU
CSB-EP669997MAAU
CSB-BP669997MAAU
CSB-MP669997MAAU
CSB-EP669997MAAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP669998MLQ
CSB-EP669998MLQ
CSB-BP669998MLQ
CSB-MP669998MLQ
CSB-EP669998MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 50S ribosomal protein L7/L12 (rplL) CSB-YP669999MLQ
CSB-EP669999MLQ
CSB-BP669999MLQ
CSB-MP669999MLQ
CSB-EP669999MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Uridylate kinase (pyrH) CSB-YP670000MLQ
CSB-EP670000MLQ
CSB-BP670000MLQ
CSB-MP670000MLQ
CSB-EP670000MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Probable GTP-binding protein EngB (engB) CSB-YP670001MLQ
CSB-EP670001MLQ
CSB-BP670001MLQ
CSB-MP670001MLQ
CSB-EP670001MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Proline--tRNA ligase (proS) CSB-YP670002MLQ
CSB-EP670002MLQ
CSB-BP670002MLQ
CSB-MP670002MLQ
CSB-EP670002MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae UPF0348 protein MHJ_0259 (MHJ_0259) CSB-YP670003MLQ
CSB-EP670003MLQ
CSB-BP670003MLQ
CSB-MP670003MLQ
CSB-EP670003MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Inosose dehydratase (iolE) CSB-YP670004MLQ
CSB-EP670004MLQ
CSB-BP670004MLQ
CSB-MP670004MLQ
CSB-EP670004MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 50S ribosomal protein L3 (rplC) CSB-YP670005MLQ
CSB-EP670005MLQ
CSB-BP670005MLQ
CSB-MP670005MLQ
CSB-EP670005MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 50S ribosomal protein L14 (rplN) CSB-YP670006MLQ
CSB-EP670006MLQ
CSB-BP670006MLQ
CSB-MP670006MLQ
CSB-EP670006MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae 30S ribosomal protein S11 (rpsK) CSB-YP670007MLQ
CSB-EP670007MLQ
CSB-BP670007MLQ
CSB-MP670007MLQ
CSB-EP670007MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Glutamate--tRNA ligase (gltX) CSB-YP670008MLQ
CSB-EP670008MLQ
CSB-BP670008MLQ
CSB-MP670008MLQ
CSB-EP670008MLQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>